Stifel keeps Buy ratings on Manhattan Associates and IQVIA
Stifel kept Buy ratings with $250 and $303 targets for Manhattan Associates and IQVIA, implying 12.3% and 16.2% upside. Data from Benzinga.
- published
- in the api
- on the website
on the website stories appear 15 minutes after publication, in the api at once. connect the api →
what happened
Stifel maintained its Buy rating on Manhattan Associates with a $250 price target, which implies 12.3% upside from the October 13 close of $222.71. According to Benzinga, the firm sees Manhattan as a leader in supply chain and omnichannel commerce software, with revenue growth expected from cloud migration and new products such as Active Agents and Editions.
The same broker kept its Buy rating on IQVIA Holdings with a $303 target, suggesting 16.2% upside from the October 13 close of $260.68. Analysts point to four quarters of steady growth in net new bookings, rising win rates and strong requests for proposal, which they believe could let IQVIA beat consensus expectations in coming quarters.
why it matters
For investors, this is one brokerage's view on two companies in enterprise software and clinical research. Analyst ratings reflect a single firm's assessment and are not a price forecast or investment recommendation.
tags
instruments
sources
- Stifel maintains Buy rating on Manhattan Associates, $250 price target — Newsmetry API, 14 October 2026 at 16:26 UTC
- Stifel maintains Buy rating on IQVIA Holdings, $303 price target — Newsmetry API, 14 October 2026 at 16:24 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
on the website stories appear 15 minutes after publication, in the api at once.
get stories in real time ↗